The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?

by Ola Rominiyi, Yahia Al-Tamimi, Spencer J. Collis
Published 2019-03-01

Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma

by Natasha Carmell, Ola Rominiyi, Katie N. Myers, Connor McGarrity-Cottrell, Aurelie Vanderlinden, Nikita Lad, Eva Perroux-David, Sherif F. El-Khamisy, Malee Fernando, Katherine G. Finegan, Stephen Brown, Spencer J. Collis
Published 2021-02-01

MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response

by Christopher J. Staples, Giancarlo Barone, Katie N. Myers, Anil Ganesh, Ian Gibbs-Seymour, Abhijit A. Patil, Ryan D. Beveridge, Caroline Daye, Richard Beniston, Sarah Maslen, Ivan Ahel, J. Mark Skehel, Spencer J. Collis
Published 2016-09-01

Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor.

by Sushant K Kachhap, Nadine Rosmus, Spencer J Collis, Madeleine S Q Kortenhorst, Michel D Wissing, Mohammad Hedayati, Shabana Shabbeer, Janet Mendonca, Justin Deangelis, Luigi Marchionni, Jianqing Lin, Naseruddin Höti, Johan W R Nortier, Theodore L DeWeese, Hans Hammers, Michael A Carducci
Published 2010-06-01